To identify candidates most likely to cause disease, we searched for additional evidence in the literature supporting the role of candidate genes in hematologic malignancies, with an emphasis on data from human lymphoid malignancies and a particular focus on BCL2-driven B cell lymphoma. This evidence concerns the gene BCL2 and hematologic disorder.